FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

job cuts news from FierceBiotech

News

SPOTLIGHT: J&J chops jobs

With Procrit under siege, Johnson & Johnson wants to divert its promotional efforts elsewhere--a strategy that will lead to some 400 job cuts in its sales-and-marketing ranks. The company told Read more...

U.S. R&D headcount tumbles in key categories

Pharmalot has been crunching the numbers for R&D jobs and concludes that the U.S. is seeing a considerable amount of shrinkage in the field. Looking at new numbers from PhRMA for 2006, R&D Read more...

SPOTLIGHT: Wyeth may cut 10% of jobs

Welcome Wyeth to the layoff parade. The drug maker is plotting cutbacks, including job cuts that could amount to 10 percent of its 50,000-person workforce. Read more...
Tags: Wyeth   job cuts  

In last act, PDL chief takes out the axe

Mark McDade has already announced that he's leaving his post as CEO of PDL BioPharma at the end of the year. And last night he Read more...

Sunesis pares staff in cost-cutting move

Sunesis Pharmaceuticals is paring 35 workers, or 25 percent of its staff, in an effort to pare out $10 million in costs. Research and general administrative areas will be cut the most as the Read more...

FDA delay forces cutbacks at GPC Biotech

Struggling to overcome FDA hurdles for its cancer drug satraplatin, Germany's GPC Biotech says it will slash its staff by 15 Read more...

What to do with Avandia sales force?

GlaxoSmithKline may cut or redeploy its Avandia sales force in the wake of safety concerns that have virtually destroyed the drugs sales. Avandia is GSK’s second bestselling drug, earning £1.4 Read more...

More cuts at troubled Point Therapeutics

The troubles at Point Therapeutics continue as the company announced today that it made major cuts to its Read more...

AstraZeneca cuts 7,600 jobs

Never willing to sit idle, AstraZeneca is whacking 7,600 workers off the payroll as it steps up Read more...

Aspreva cuts a quarter of its jobs as it refocuses

Canada's Aspreva Pharmaceuticals says that Chief Scientific Officer Richard Jones is leaving the company as the biotech cuts 33 jobs, or about a quarter of its work force. Company officials say they Read more...